In the December update we basically threw in the towel on YAYO at 20 cents, DEFTF at 12 cents, PCSA stopped out at 1.50 since, ATOM stopped out at 7.50 since, and WARM. MEEC, BIVI, GANX were suggested buys/adds at the time in the early December...
BIVI 9.75 Well I had us take profits, then the stock ripped higher again. But importantly, they withdrew the S-1 Stock Offering filing UNEXPECTEDLY on Monday morning this week. I now believe perhaps they have another funding source of higher value, partner etc which they have publicly...
PCSA $1.85 per share close of 12/9/22 Market cap: 16 million shares x $1.85 or 30 million, 9 million cash. Tax selling should be nearly over here, and at $1.85 per share we are trading at 30 million market cap with 2 front runners in development for...
Major action on BIVI stock, let's catch up BIVI 4.60 close of 12/6 Rallied to 8 area highs from 3.90 report on Oct 21. We ended up with great data sets on both Alzheimers and Parkinsons. I was on the phone with Life Sci Advisors last night...
A few recent reports first BUYS- BIVI, GANX, MEEC BIVI- Biovie hit a high of 7.70 today from my 3.92 report on Oct 25th. Nearly a double already and it pulled back to 3.60 after my report. I've been buying steady ever since on all dips to...
Had a phone call this morning with MEEC very bullish, notes below the BIVI update BIVI- 5.44 new uptrend high today The stock up from 3.90 report and has potential to get to $40 a share ahead based on the comparative valuation of SAVA and relative data...
Two most recent recommendations are GANX and BIVI. BIVI smashed as high as 4.96 today and I was writing it up around 3.90 a few weeks ago here. Now at 4.62 I am buying more almost every day as I believe the stock can run materially...
RSASF- ReSaas .18, 15 million market cap Currently trading at a fraction of potential business valuation. That is the market we are in right now, but could turn on a dime as most bear markets obviously end at some point. Again, if they get their subscription revenues...
BIVI 3.99 Close of 11/2/22 Some quick notes on Biovie, my most recent recommendation. This is a tough small cap and growth stock market still until the Fed slows down rate hikes, however there are diamonds in the rough. One of which looks like Biovie which...
GANX 3.18- Strong Buy Target remains $11 to $30 potential Market Cap 38 million Cash 33 Million Enterprise Value 5 million This was our last TPS research report in July around $4 a share then. Not much has changed in the story, but what has changed is SIGNIFICANT interest...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
